Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5702666 | Urologic Oncology: Seminars and Original Investigations | 2017 | 10 Pages |
Abstract
Hypofractionated RT delivers a larger dose of daily radiation compared to conventional IMRT, and thus reduces the overall treatment time and possibly cost. An extreme form of hypofractionation is stereotactic body radiation therapy where highly precise radiation is used and treatment is completed in a total of 4 to 5 sessions. These techniques take advantage of the biological characteristic of prostate cancer, which is more sensitive to larger radiation doses per fraction, and therefore could be more effective than conventional IMRT. Multiple randomized trials have demonstrated noninferiority of moderately hypofractionated RT compared to conventional fractionation. There is also a growing body of data demonstrating the safety and efficacy of stereotactic body radiation therapy for low- and intermediate-risk prostate cancer.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Dominic H. M.D., Jason A. M.D., D.Phil., Ronald C. M.D., M.P.H.,